175 related articles for article (PubMed ID: 16864928)
1. Amiodarone therapy in patients implanted with cardioverter-defibrillator for life-threatening ventricular arrhythmias.
Satomi K; Kurita T; Takatsuki S; Yokoyama Y; Chinushi M; Tsuboi N; Nitta T; Shoda M; Mitamura H
Circ J; 2006 Aug; 70(8):977-84. PubMed ID: 16864928
[TBL] [Abstract][Full Text] [Related]
2. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
[TBL] [Abstract][Full Text] [Related]
3. Differences in amiodarone efficacy in relation to ejection fraction and basal rhythm in patients with implantable cardioverter defibrillators.
Watanabe T; Inoue K; Kashiwase K; Mine T; Hirooka K; Shutta R; Mizuno H; Okuyama Y; Sakata Y; Nanto S;
J Electrocardiol; 2018; 51(6):1111-1115. PubMed ID: 30497740
[TBL] [Abstract][Full Text] [Related]
4. Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.
Connolly SJ; Gent M; Roberts RS; Dorian P; Roy D; Sheldon RS; Mitchell LB; Green MS; Klein GJ; O'Brien B
Circulation; 2000 Mar; 101(11):1297-302. PubMed ID: 10725290
[TBL] [Abstract][Full Text] [Related]
5. Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone.
Gali WL; Sarabanda AV; Baggio JM; Ferreira LG; Gomes GG; Marin-Neto JA; Junqueira LF
Europace; 2014 May; 16(5):674-80. PubMed ID: 24481778
[TBL] [Abstract][Full Text] [Related]
6. Improved survival of cardiac transplantation candidates with implantable cardioverter defibrillator therapy: role of beta-blocker or amiodarone treatment.
Ermis C; Zadeii G; Zhu AX; Fabian W; Collins J; Lurie KG; Sakaguchi S; Benditt DG
J Cardiovasc Electrophysiol; 2003 Jun; 14(6):578-83. PubMed ID: 12875416
[TBL] [Abstract][Full Text] [Related]
7. [Antiarrhythmic therapy in patients with heart failure].
Faber TS; Zehender M
Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
[TBL] [Abstract][Full Text] [Related]
8. Management of patients with life-threatening sustained ventricular tachyarrhythmias--the role of guided antiarrhythmic drug therapy.
Steinbeck G; Greene HL
Prog Cardiovasc Dis; 1996; 38(6):419-28. PubMed ID: 8638023
[TBL] [Abstract][Full Text] [Related]
9. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
Klein H; Auricchio A; Reek S; Geller C
Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
[TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
Bollmann A; Husser D; Cannom DS
Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
[TBL] [Abstract][Full Text] [Related]
11. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
Ho AT; Pai SM; Timothy P; Pai RG
Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799
[TBL] [Abstract][Full Text] [Related]
12. Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction.
Sanders GD; Hlatky MA; Every NR; McDonald KM; Heidenreich PA; Parsons LS; Owens DK
Ann Intern Med; 2001 Nov; 135(10):870-83. PubMed ID: 11712877
[TBL] [Abstract][Full Text] [Related]
13. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
Wilkoff BL; Cook JR; Epstein AE; Greene HL; Hallstrom AP; Hsia H; Kutalek SP; Sharma A;
JAMA; 2002 Dec; 288(24):3115-23. PubMed ID: 12495391
[TBL] [Abstract][Full Text] [Related]
14. Japanese randomized trial for investigation of a combined therapy of amiodarone and implantable cardioverter defibrillator in patients with ventricular tachycardia and fibrillation: the Nippon ICD Plus Pharmachologic Option Necessity study design.
Kurita T; Mitamura H; Aizawa Y; Nitta T; Aonuma K; Tsuboi N; Chinushi M; Kobayashi Y; Soejima K; Satomi K; Furushima H; Ohe T; Ogawa S; Kodama I; Ohtsu H; Yamazaki T;
Circ J; 2006 Mar; 70(3):316-20. PubMed ID: 16501299
[TBL] [Abstract][Full Text] [Related]
15. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators.
Domanski MJ; Sakseena S; Epstein AE; Hallstrom AP; Brodsky MA; Kim S; Lancaster S; Schron E
J Am Coll Cardiol; 1999 Oct; 34(4):1090-5. PubMed ID: 10520795
[TBL] [Abstract][Full Text] [Related]
16. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
[TBL] [Abstract][Full Text] [Related]
17. Amiodarone -- waxed and waned and waxed again.
Doggrell SA
Expert Opin Pharmacother; 2001 Nov; 2(11):1877-90. PubMed ID: 11825323
[TBL] [Abstract][Full Text] [Related]
18. Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.
Raitt MH; Klein RC; Wyse DG; Wilkoff BL; Beckman K; Epstein AE; Coromilas J; Friedman PL; Martins J; Ledingham RB; Greene HL;
Am J Cardiol; 2003 Apr; 91(7):812-6. PubMed ID: 12667566
[TBL] [Abstract][Full Text] [Related]
19. THE SAFETY AND EFFICACY OF AMIODARONE AND CARVEDILOL COMBINATION IN TREATMENT OF PATIENTS WITH SEVERE CARDIAC RHYTHM DISORDERS.
Tsetskhladze E; Khintibidze I
Georgian Med News; 2017 Jun; (267):53-57. PubMed ID: 28726654
[TBL] [Abstract][Full Text] [Related]
20. Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent.
Singh BN
Am J Cardiol; 1996 Aug; 78(4A):41-53. PubMed ID: 8780328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
